Summary by Futu AI
Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 6,000 shares of the company's Class A Common Stock on July 25, 2024. The transaction was executed at a price of $8.1349 per share, resulting in a total market value of $48,809.40. Prior to this sale, Marriott exercised an equivalent number of shares at a price of $1.06 each. Following the transactions, Marriott's direct holdings in Recursion Pharmaceuticals amount to 535,457 shares.